Have we overlooked the importance of serine/threonine protein phosphatases in pancreatic beta-cells? Role played by protein phosphatase 2A in insulin secretion

Journal of the Pancreas

Volumn 6, Issue 4, 2005, Pages 303-315

  Parameswara, Vinay Kumar ^a   Sule, Aditi Jagdish ^a   Esser, Victoria ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Insulin; Islets of Langerhans; Phosphoprotein phosphatase; Phosphorylation

Indexed keywords

GLUCOSE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE; CALCINEURIN; INSULIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE;

CELL LINE; CELL METABOLISM; DIABETES MELLITUS; DRUG RESEARCH; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME MECHANISM; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; ENZYMOLOGY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PHOSPHORYLATION; PHYSIOLOGY; SECRETION;

CALCINEURIN; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; ISLETS OF LANGERHANS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 27244432413     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Segal KR. Type 2 diabetes and disease management: exploring the connections. Dis Manag 2004; 7(Suppl 1):S11-22.
2. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144:5159-65.
3. Reitman ML. Metabolic lessons from genetically lean mice Annu Rev Nutr 2002; 22:459-82.
4. Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med 2003; 4(Suppl 6):S3-10.
5. Scheen AJ. Pathophysiology of insulin secretion. Ann Endocrinol (Paris) 2004; 65:29-36.
6. Portha B. Transmitted beta-cell dysfunction as a cause for type 2-diabetes. Med Sci (Paris) 2003; 19:847-53.
7. Sesti G. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Ann Med 2002; 34:444-50.
8. Flatt PR, Shibier O, Szecowka J, Berggren PO. New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic beta-cell. Diabete Metab 1994; 20:157-62.
9. Bratanova-Tochkova TK, Cheng H, Daniel S, Gunawardana S, Liu YJ, Mulvaney-Musa J, et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002; 51(Suppl 1):S83-90.
10. Holz GG. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 2004; 53:5-13.
11. Nakano K, Suga S, Takeo T, Ogawa Y, Suda T, Kanno T, Wakui M. Intracellular Ca(2+) modulation of ATP-sensitive K(+) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells. Endocrinology 2002; 143:569-76.
12. Bergsten P. Role of oscillations in membrane potential, cytoplasmic Ca2+, and metabolism for plasma insulin oscillations. Diabetes 2002; 51(Suppl 1):S171-6.
13. Wilson JR, Ludowyke RI, Biden TJ. Nutrient stimulation results in a rapid Ca2+-dependent threonine phosphorylation of myosin heavy chain in rat pancreatic islets and RINm5F cells. J Biol Chem 1998; 273:22729-37.
14. Krueger KA, Bhatt H, Landt M, Easom RA. Calcium-stimulated phosphorylation of MAP-2 in pancreatic betaTC3-cells is mediated by Ca2+/calmodulin-dependent kinase II. J Biol Chem 1997; 272:27464-9.
15. Nesher R, Anteby E, Yedovizky M, Warwar N, Kaiser N, Cerasi E. Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 2002; 51(Suppl 1):S68-73.
16. Jones PM, Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells. Endocr Rev 1998; 19:429-61.
17. Easom RA. CaM kinase II: a protein kinase with extraordinary talents germane to insulin exocytosis. Diabetes 1999; 48:675-84.
18. Radosavljevic T, Todorovic V, Sikic B. Insulin secretion: mechanisms of regulation. Med Pregl 2004; 57:249-53.
19. Lee T, Sumpio BE. Cell signalling in vascular cells exposed to cyclic strain: the emerging role of protein phosphatases. Biotechnol Appl Biochem 2004; 39(Pt 2):129-39.
20. Klumpp S, Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2002; 2:458-62.
21. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem J 1995; 311(Pt. 1):17-29.
22. Hunter T. Signaling - 2000 and beyond. Cell 2000; 100:113-27.
23. Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, et al. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 2003; 85:721-6.
24. Keyse SM. An emerging family of dual specificity MAP kinase phosphatases. Biochim Biophys Acta 1995; 1265:152-60.
25. Laboratory of Marc Mumby at the University of Texas Southwestern Medical Center. Protein serine/threonine phosphatases (Viewed on May 13th, 2005). http://www4.utsouthwestern.edu/mumbylab/PPPTBL.htm
26. Price NE, Mumby MC. Brain protein serine/threonine phosphatases. Curr Opin Neurobiol 1999; 9:336-42.
27. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58:453-508.
28. Ammon HP, Heurich RO, Kolb HA, Lang F, Schaich R, Drews G, Leiers T. The phosphatase inhibitor okadaic acid blocks KCl-depolarization-induced rise of cytosolic calcium of rat insulinoma cells (RINm5F). Naunyn Schmiedebergs Arch Pharmacol 1996; 354:95-101.
29. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001; 414:807-12.
30. Lehtihet M, Honkanen RE, Sjoholm A. Glutamate inhibits protein phosphatases and promotes insulin exocytosis in pancreatic beta-c.ells Biochem Biophys Res Commun 2005; 328:601-7.
31. Larsson O, Barker CJ, Sjoholm A, Carlqvist H, Michell RH, Bertorello A, et al. Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate. Science 1997; 278:471-4.
32. Sjoholm A, Honkanen RE. Polyamines regulate serine/threonine protein phosphatases in insulin-secreting cells. Pancreas 2000; 20:32-7.
33. Gagliardino, J. J., Rossi, P. F., and Garcia, M. E. Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets. Acta Diabetol 1997; 34:6-9.
34. Lehtihet M, Honkanen RE, Sjoholm A. Inositol hexakisphosphate and sulfonylureas regulate beta-cell protein phosphatases. Biochem Biophys Res Commun 2004; 316:893-7.
35. Van Hoof C, Goris J. PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 2004; 5:105-6.
36. Hemmings BA, Adams-Pearson C, Maurer F, Muller P, Goris J, Merlevede W, et al. alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure. Biochemistry 1990; 29:3166-73.
37. McCright B, Rivers AM, Audlin S, Virshup DM. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 1996; 271:22081-9.
38. Strack S, Zaucha JA, Ebner FF, Colbran RJ, Wadzinski BE. Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J Comp Neurol 1998; 392:515-27.
39. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature 1994; 371:297-300.
40. Moreno CS, Park S, Nelson K, Ashby D, Hubalek F, Lane WS, Pallas DC. WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. J Biol Chem 2000; 275:5257-63.
41. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24:186-91.
42. Yan L, Nairn AC, Palfrey HC, Brady MJ. Glucose regulates EF-2 phosphorylation and protein translation by a protein phosphatase-2A-dependent mechanism in INS-1-derived 832/13 cells. J Biol Chem 2003; 278:18177-83.
43. Barford D. Molecular mechanisms of the protein serine/threonine phosphatases. Trends Biochem Sci 1996; 21:407-12.
44. Mayer P, Jochum C, Schatz H, Pfeiffer A. Okadaic acid indicates a major function for protein phosphatases in stimulus-response coupling of RINm5F rat insulinoma cells Exp Clin Endocrinol 1994; 102:313-9.
45. Ratcliff H, Jones PM. Effects of okadaic acid on insulin secretion from rat islets of Langerhans. Biochim Biophys Acta 1993; 1175:188-91.
46. MacKintosh C, Klumpp S. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett 1990; 277:137-40.
47. Walsh AH, Cheng A, Honkanen RE. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett 1997; 416:230-4.
48. Weinbrenner C, Baines CP, Liu GS, Armstrong SC, Ganote CE, Walsh AH, et al. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 1998; 98:899-905.
49. Rakwal R, Kumar Agrawal G, Jwa NS. Characterization of a rice (Oryza sativa L.) Bowman-Birk proteinase inhibitor: tightly light regulated induction in response to cut, jasmonic acid, ethylene and protein phosphatase 2A inhibitors. Gene 2001; 263:189-98.
50. Haby C, Larsson O, Islam MS, Aunis D, Berggren PO, Zwiller J. Inhibition of serine/threonine protein phosphatases promotes opening of voltage-activated L-type Ca2+ channels in insulin-secreting cells. Biochem J 1994; 298(Pt 2):341-6.
51. Ammala C, Eliasson L, Bokvist K, Berggren PO, Honkanen RE, Sjoholm A, Rorsman P. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci U S A 1994; 91:4343-7.
52. Tamagawa T, Iguchi A, Uemura K, Miura H, Nonogaki K, Ishiguro T, Sakamoto N. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets. Endocrinol Jpn 1992; 39:325-9.
53. Sato Y, Mariot P, Detimary P, Gilon P, Henquin JC. Okadaic acid-induced decrease in the magnitude and efficacy of the Ca2+ signal in pancreatic beta cells and inhibition of insulin secretion. Br J Pharmacol 1998; 123:97-105.
54. Herzig S, Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 2000; 80:173-210.
55. Sjoholm A, Honkanen RE, Berggren PO. Inhibition of serine/threonine protein phosphatases by secretagogues in insulin-secreting cells. Endocrinology 1995; 136:3391-7.
56. Sjoholm A, Lehtihet M, Efanov AM, Zaitsev SV, Berggren PO, Honkanen RE. Glucose metabolites inhibit protein phosphatases and directly promote insulin exocytosis in pancreatic beta-cells. Endocrinology 2002; 143:4592-8.
57. Erickson AK, Killilea SD. Effects of fructose 2,6-bisphosphate and glucose 1,6-bisphosphate on porcine heart protein phosphatase 2A. Biochem Int 1992; 27:353-9.
58. Pek SB, Usami M, Bilir N, Fischer-Bovenkerk C, Ueda T. Protein phosphorylation in pancreatic islets induced by 3-phosphoglycerate and 2-phosphoglycerate. Proc Natl Acad Sci U S A 1990; 87:4294-8.
59. Tolstykh T, Lee J, Vafai S, Stock JB. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 2000; 19:5682-91.
60. Kowluru A, Seavey SE, Rabaglia ME, Nesher R, Metz SA. Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology 1996; 137:2315-23.
61. Wu J, Tolstykh T, Lee J, Boyd K, Stock JB, Broach JR. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. EMBO J 2000; 19:5672-81.
62. Sjoholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett 1995; 367:283-6. t
63. De Baere I, Derua R, Janssens V, Van Hoof C, Waelkens E, Merlevede W, Goris J. Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry. 1999; 38:16539-47.
64. Zhu T, Matsuzawa S, Mizuno Y, Kamibayashi C, Mumby MC, Andjelkovic N, et al. The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells. Arch Biochem Biophys 1997; 339:210-7.
65. Oliver CJ, Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front Biosci 1998; 3:D961-72.
66. Virshup DM. Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol 2000; 12:180-5.
67. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993; 268:15523-30.
68. Kwon G, Bohrer A, Han X, Corbett JA, Ma Z, Gross RW, et al. Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Biochim Biophys Acta 1996; 1300:63-72.
69. Kowluru A, Metz SA. Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Lett 1997; 418:179-82.
70. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297-303.
71. Major CD, Gao ZY, Wolf BA. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death. Diabetes 1999; 48:1372-80.
72. Saldeen J, Jaffrezou JP, Welsh N. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F. Autoimmunity 2000; 32:241-54.
73. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997; 100:398-403.
74. Guo H, Damuni Z. Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A. Proc Natl Acad Sci U S A 1993; 90:2500-4.
75. Brautigan DL. Flicking the switches: phosphorylation of serine/threonine protein phosphatases. Semin Cancer Biol 1995; 6:211-7.
76. Aggen JB, Nairn AC, Chamberlin R. Regulation of protein phosphatase-1. Chem Biol 2000; 7:R13-23.
77. Villafranca JE, Kissinger CR, Parge HE. Protein serine/threonine phosphatases. Curr Opin Biotechnol 1996; 7:397-402.
78. Ceulemans H, Stalmans W, Bollen M. Regulator-driven functional diversification of protein phosphatase-1 in eukaryotic evolution. Bioessays 2002; 24:371-81.
79. Bollen M. Combinatorial control of protein phosphatase-1. Trends Biochem Sci 2001; 26:426-31.
80. Easom RA, Tarpley JL, Filler NR, Bhatt H. Dephosphorylation and deactivation of Ca2+/calmodulin-dependent protein kinase II in betaTC3-cells is mediated by Mg2+- and okadaic-acid-sensitive protein phosphatases. Biochem J 1998; 329(Pt 2):283-8.
81. Lilja L, Meister B, Berggren PO, Bark C. DARPP32 and inhibitor-1 are expressed in pancreatic beta-cells. Biochem Biophys Res Commun 2005; 329:673-7.
82. Klee CB, Crouch TH, Krinks MH. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 1979; 76:6270-3.
83. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002; 109(Suppl):S67-79.
84. Lawrence MC, Bhatt HS, Watterson JM, Easom RA. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol 2001; 15:1758-67.
85. Ippoliti GB, Vigano M. Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus. G Ital Nefrol 2003; 20(Suppl 25):S11-4.
86. Renstrom E, Ding WG, Bokvist K, Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 1996; 17:513-22.
87. Donelan MJ, Morfini G, Julyan R, Sommers S, Hays L, Kajio H, et al. Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis. J Biol Chem 2002; 277:24232-42.
88. Kloeker S, Wadzinski BE. Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J Biol Chem 1999; 274:5339-47.
89. Lewy DS, Gauss CM, Soenen DR, Boger DL. Fostriecin: chemistry and biology. Curr Med Chem 2002; 9:2005-32.
90. Chinkers M. Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 2001; 12:28-32.
91. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PT. A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 1994; 13:4278-90.
92. Lubert EJ, Hong Y, Sarge KD. Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: evidence for a heterotrimeric form of protein phosphatase 5. J Biol Chem 2001; 276:38582-7.
93. Bastians H, Krebber H, Vetrie D, Hoheisel J, Lichter P, Ponstingl H, Joos S. Localization of the novel serine/threonine protein phosphatase 6 gene (PPP6C) to human chromosome Xq22.3. Genomics 1997; 41:296-7.
94. Filali M, Li S, Kim HW, Wadzinski B, Kamoun M. Identification of a type 6 protein ser/thr phosphatase regulated by interleukin-2 stimulation. J Cell Biochem 1999; 73:153-63.
95. Kutuzov MA, Bennett N, Andreeva AV. Interaction of plant protein Ser/Thr phosphatase PP7 with calmodulin. Biochem Biophys Res Commun 2001; 289:634-40.
96. Meskiene I, Baudouin E, Schweighofer A, Liwosz A, Jonak C, Rodriguez PL, et al. Stress-induced protein phosphatase 2C is a negative regulator of a mitogen-activated protein kinase. J Biol Chem 2003; 278:18945-52.
97. Chen J, Ostenson CG. Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats. Pancreas 2005; 30:314-7.
98. Kapp K, Metzinger E, Kellerer M, Haring HU, Lammers R. The protein tyrosine phosphatase alpha modifies insulin secretion in INS-1E cells. Biochem Biophys Res Commun 2003; 311:361-4.
99. Pratley RE, Weyer C. Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion. Curr Diab Rep 2002; 2:242-8.